Business Standard

Saturday, December 21, 2024 | 07:34 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Gland Pharma receives Sebi's go-ahead to launch IPO pegged at Rs 5,000 cr

Apart from the fresh issue, there is an offer for sale (OFS) of a little over 34 million shares as part of the IPO

IPO
Premium

The Hyderabad-based company, backed by China's Fosun Pharma, develops, manufactures and markets complex injectables

Press Trust of India
Gland Pharma has received capital markets regulator Sebi's go-ahead to launch an initial public offering (IPO) that includes fresh issue of shares worth up to Rs 1,250 crore. According to investment banking sources, the IPO would be worth over Rs 5,000 crore. 
 
Apart from the fresh issue, there is an offer for sale (OFS) of a little over 34 million shares as part of the IPO.
 
The Hyderabad-based company, backed by China's Fosun Pharma, develops, manufactures and markets complex injectables.
 
The company filed draft papers in July and obtained Sebi's observation on October 19 to float an IPO, an update

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in